Dr Reddys Laboratories (RDY) Payables (2009 - 2026)
Dr Reddys Laboratories (RDY) reported Payables of $1.01 billion for the quarter ended Jun 30, 2026, up 13.5% from $886.15 million a year earlier but down 0.7% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Payables (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Dr Reddys Laboratories posted Payables of $986 million, up 14.4% from the prior year.
- Payables has increased for three consecutive years, with a five-year compound annual growth rate of 9.0% (years ended Mar 2021 to Mar 2026).
- By year, Payables came in at $862 million in the year ended Mar 31, 2025 (+64.5%), $524 million in the year ended Mar 31, 2024 (+27.2%), $412 million in the year ended Mar 31, 2023 (-40.6%) and $694 million in the year ended Mar 31, 2022 (+8.3%).
- Five-year quarterly Payables spans a low of $411.59 million in the quarter ended Mar 31, 2023 and a high of $1.02 billion in the quarter ended Dec 31, 2025.
- Year over year, Payables has now increased in each of the last 12 quarters, with growth averaging 40.1% over the last eight quarters.
- The high point for year-over-year Payables in five years was the quarter ended Sep 30, 2024 (growth of 105.8%); the low point was the quarter ended Mar 31, 2023 (a decline of 41.2%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $1.01 billion (quarter ended Mar 31, 2026), $1.02 billion (quarter ended Dec 31, 2025) and $933.26 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Dr Reddys Laboratories | 10.44 Bn | 9.62 Bn | 396.53 Mn | 1.01 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Bn |
| Mar 31, 2026 | 1.01 Bn |
| Dec 31, 2025 | 1.02 Bn |
| Sep 30, 2025 | 933.26 Mn |
| Jun 30, 2025 | 886.15 Mn |
| Mar 31, 2025 | 849.57 Mn |
| Dec 31, 2024 | 928.81 Mn |
| Sep 30, 2024 | 904.43 Mn |
| Jun 30, 2024 | 686.58 Mn |
| Mar 31, 2024 | 525.52 Mn |
| Dec 31, 2023 | 521.90 Mn |
| Sep 30, 2023 | 439.51 Mn |
| Jun 30, 2023 | 415.73 Mn |
| Mar 31, 2023 | 411.59 Mn |
| Dec 31, 2022 | 456.64 Mn |
| Sep 30, 2022 | 420.78 Mn |
| Jun 30, 2022 | 537.15 Mn |
| Mar 31, 2022 | 700.25 Mn |
| Dec 31, 2021 | 611.58 Mn |
| Sep 30, 2021 | 660.40 Mn |
API Access
Dr Reddys Laboratories Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();